Your browser doesn't support javascript.
loading
Can (We Make) Bacillus thuringiensis Crystallize More Than Its Toxins?
Tetreau, Guillaume; Andreeva, Elena A; Banneville, Anne-Sophie; De Zitter, Elke; Colletier, Jacques-Philippe.
Affiliation
  • Tetreau G; Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38000 Grenoble, France.
  • Andreeva EA; Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38000 Grenoble, France.
  • Banneville AS; Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38000 Grenoble, France.
  • De Zitter E; Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38000 Grenoble, France.
  • Colletier JP; Univ. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38000 Grenoble, France.
Toxins (Basel) ; 13(7)2021 06 26.
Article in En | MEDLINE | ID: mdl-34206749
ABSTRACT
The development of finely tuned and reliable crystallization processes to obtain crystalline formulations of proteins has received growing interest from different scientific fields, including toxinology and structural biology, as well as from industry, notably for biotechnological and medical applications. As a natural crystal-making bacterium, Bacillus thuringiensis (Bt) has evolved through millions of years to produce hundreds of highly structurally diverse pesticidal proteins as micrometer-sized crystals. The long-term stability of Bt protein crystals in aqueous environments and their specific and controlled dissolution are characteristics that are particularly sought after. In this article, I explore whether the crystallization machinery of Bt can be hijacked as a means to produce (micro)crystalline formulations of proteins for three different applications (i) to develop new bioinsecticidal formulations based on rationally improved crystalline toxins, (ii) to functionalize crystals with specific characteristics for biotechnological and medical applications, and (iii) to produce microcrystals of custom proteins for structural biology. By developing the needs of these different fields to figure out if and how Bt could meet each specific requirement, I discuss the already published and/or patented attempts and provide guidelines for future investigations in some underexplored yet promising domains.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacillus thuringiensis / Bacterial Proteins / Bacillus thuringiensis Toxins Language: En Journal: Toxins (Basel) Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacillus thuringiensis / Bacterial Proteins / Bacillus thuringiensis Toxins Language: En Journal: Toxins (Basel) Year: 2021 Document type: Article Affiliation country: